EdiGene Inc.
π¨π³China
- Country
- π¨π³China
- Ownership
- Holding
- Established
- 2015-05-25
- Employees
- 101
- Market Cap
- -
- Website
- https://www.edigene.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus
Phase 1
Not yet recruiting
- Conditions
- Lupus Erythematosus, Systemic
- Interventions
- First Posted Date
- 2024-04-18
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- EdiGene Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT06373991
- Locations
- π¨π³
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China
News
No news found